PMID: 9431896Feb 12, 1998Paper

Effects of long-term course of alpha-interferon in patients with chronic hepatitis C associated to mixed cryoglobulinaemia

European Journal of Gastroenterology & Hepatology
L E AdinolfiG Ruggiero

Abstract

To evaluate the efficacy of a long-term course of alpha-interferon (alpha-IFN) in the treatment of HCV-related mixed cryoglobulinaemia and to determine the impact of cryoglobulinaemia on therapeutic response to IFN in chronic hepatitis C (CHC) patients. Prospective controlled study. University Medical Centre. Ninety consecutive CHC patients, 50 with cryoglobulinaemia (25 symptomatic and 25 asymptomatic; median cryocrit, 8%; chronic persistent hepatitis (CPH) 7, chronic active hepatitis (CAH) 27, cirrhosis 16) and 40 without cryoglobulinaemia (CPH 6, CAH 20, cirrhosis 14). HCV genotypes in the cryoglobulinaemic and non-cryoglobulinaemic groups were: 1b 40% and 45%; 2a 40% and 30%; others 20% and 25%, respectively. Twelve-month course of alpha-IFN 2a, 3 MU, three times weekly. Disappearance of cryoglobulinaemia and related syndrome, clearance of serum HCV RNA and normalization serum transaminase levels at the end of treatment (response) and after 12 months follow-up (sustained response). Overall, cryoglobulinaemic patients showed a similar response to IFN to those without cryoglobulinaemia (44% vs. 42.5%, respectively). In the cryoglobulinaemic group, symptomatic patients showed a lower response rate than asymptomatic patients (2...Continue Reading

Citations

Mar 29, 2002·Arthritis and Rheumatism·Dimitrios Vassilopoulos, Leonard H Calabrese
Oct 25, 2012·Internal and Emergency Medicine·Anna Linda ZignegoGiacomo Laffi
Nov 4, 2006·Current Treatment Options in Gastroenterology·Zeid KayaliWarren N Schmidt
Dec 23, 1999·Therapeutic Apheresis : Official Journal of the International Society for Apheresis and the Japanese Society for Apheresis·H KiyomotoS Yuasa
Sep 26, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Zeid KayaliWarren N Schmidt
Apr 17, 2013·Journal of Medical Virology·Fabrizio FabriziPiergiorgio Messa
Jan 13, 2006·Gastroenterology·Jules L Dienstag, John G McHutchison
Jul 13, 2000·Baillière's Best Practice & Research. Clinical Gastroenterology·S J Hadziyannis, D Vassilopoulos
Jul 6, 2004·Alimentary Pharmacology & Therapeutics·J MedinaR Moreno-Otero
Apr 29, 2000·Lupus·M Ramos-CasalsJ Font
Jun 10, 2000·Journal of Viral Hepatitis·L A KondiliA Mele
Dec 20, 2014·The Cochrane Database of Systematic Reviews·Tim J BensteadNatalie E Parks
Apr 9, 2001·Hospital Medicine·H J Tan, D Eadington
Nov 26, 2003·The American Journal of Gastroenterology·Luigi E Adinolfi
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Maureen M Jonas
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Doris B Strader
Apr 2, 2004·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Doris B StraderUNKNOWN American Association for the Study of Liver Diseases
Jul 30, 2009·Journal of Viral Hepatitis·S-M Alavian, S-V Tabatabaei
Dec 24, 2014·Expert Review of Clinical Immunology·Anna Linda ZignegoClodoveo Ferri
Mar 6, 2015·World Journal of Gastroenterology : WJG·Luigi Elio AdinolfiAldo Marrone
Apr 6, 1999·The American Journal of Medicine·L Daghestani, C Pomeroy
Mar 15, 2003·Journal of the American Academy of Dermatology·David F Fiorentino
Jan 8, 2000·Hematology/oncology Clinics of North America·A Dispenzieri, P D Gorevic
Dec 24, 2004·La Presse médicale·Pascal Cohen, Loïc Guillevin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.